S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Xi asks Starbucks' Schultz to help repair US-China ties
Closing prices for crude oil, gold and other commodities
US blacklists Xiaomi, CNOOC, Skyrizon, raising heat on China
Stocks fall as economy's pain deepens, head for weekly loss
JPMorgan's profits jump as economy, investment bank recovers
Stocks fall as economic pain deepens, rally runs out of gas
Wells Fargo 4Q profit rose 4%, tops Street estimates
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Xi asks Starbucks' Schultz to help repair US-China ties
Closing prices for crude oil, gold and other commodities
US blacklists Xiaomi, CNOOC, Skyrizon, raising heat on China
Stocks fall as economy's pain deepens, head for weekly loss
JPMorgan's profits jump as economy, investment bank recovers
Stocks fall as economic pain deepens, rally runs out of gas
Wells Fargo 4Q profit rose 4%, tops Street estimates
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Xi asks Starbucks' Schultz to help repair US-China ties
Closing prices for crude oil, gold and other commodities
US blacklists Xiaomi, CNOOC, Skyrizon, raising heat on China
Stocks fall as economy's pain deepens, head for weekly loss
JPMorgan's profits jump as economy, investment bank recovers
Stocks fall as economic pain deepens, rally runs out of gas
Wells Fargo 4Q profit rose 4%, tops Street estimates
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Xi asks Starbucks' Schultz to help repair US-China ties
Closing prices for crude oil, gold and other commodities
US blacklists Xiaomi, CNOOC, Skyrizon, raising heat on China
Stocks fall as economy's pain deepens, head for weekly loss
JPMorgan's profits jump as economy, investment bank recovers
Stocks fall as economic pain deepens, rally runs out of gas
Wells Fargo 4Q profit rose 4%, tops Street estimates
Log in
OTCMKTS:NWPHF

Newron Pharmaceuticals Stock Forecast, Price & News

$2.44
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.44
Now: $2.44▼
$2.44
50-Day Range
$1.96
MA: $2.36▼
$2.47
52-Week Range
$1.80
Now: $2.44▼
$8.90
Volume20,000 shs
Average Volume4,170 shs
Market Capitalization$43.56 million
P/E RatioN/A
Dividend YieldN/A
Beta0.53
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease. Its pipeline of products include Sarizotan for patients with Rett syndrome; Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.
Newron Pharmaceuticals logo

MarketRank™

Overall MarketRank™

0.42 out of 5 stars

Medical Sector

1448th out of 1,480 stocks

Pharmaceutical Preparations Industry

608th out of 612 stocks

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NWPHF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.newron.com
Phone39026103461
Employees26

Debt

Debt-to-Equity Ratio0.91
Current Ratio9.39
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$7.88 million
Price / Sales5.53
Cash FlowN/A
Price / Cash FlowN/A
Book Value$2.31 per share
Price / Book1.06

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares17,850,000
Market Cap$43.56 million
Next Earnings Date3/4/2021 (Estimated)
OptionableNot Optionable
$2.44
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NWPHF News and Ratings via Email

Sign-up to receive the latest news and ratings for NWPHF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Newron Pharmaceuticals (OTCMKTS:NWPHF) Frequently Asked Questions

How has Newron Pharmaceuticals' stock price been impacted by Coronavirus (COVID-19)?

Newron Pharmaceuticals' stock was trading at $7.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NWPHF shares have decreased by 67.5% and is now trading at $2.4406.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Newron Pharmaceuticals?

Wall Street analysts have given Newron Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Newron Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Newron Pharmaceuticals' next earnings date?

Newron Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, March 4th 2021.
View our earnings forecast for Newron Pharmaceuticals.

Who are some of Newron Pharmaceuticals' key competitors?

Some companies that are related to Newron Pharmaceuticals include NeuBase Therapeutics (NBSE), scPharmaceuticals (SCPH), Taiwan Liposome (TLC), Eyenovia (EYEN), FS Development (FSDC), Ritter Pharmaceuticals (RTTR), Ovid Therapeutics (OVID), vTv Therapeutics (VTVT), Spring Bank Pharmaceuticals (SBPH), Onconova Therapeutics (ONTX), Genprex (GNPX), Aptevo Therapeutics (APVO), InflaRx (IFRX), ContraFect (CFRX) and Immunome (IMNM).
View all of NWPHF's competitors.

Who are Newron Pharmaceuticals' key executives?

Newron Pharmaceuticals' management team includes the following people:
  • Mr. Stefan Weber, CEO & Exec. Director (Age 56)
  • Mr. Roberto Galli, VP of Fin.
  • Mr. Marco Caremi, Exec. VP of Bus. Devel. (Age 64)
  • Dr. Ravi Anand, Chief Medical Officer (Age 64)

What is Newron Pharmaceuticals' stock symbol?

Newron Pharmaceuticals trades on the OTCMKTS under the ticker symbol "NWPHF."

How do I buy shares of Newron Pharmaceuticals?

Shares of NWPHF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Newron Pharmaceuticals' stock price today?

One share of NWPHF stock can currently be purchased for approximately $2.44.

How big of a company is Newron Pharmaceuticals?

Newron Pharmaceuticals has a market capitalization of $43.56 million and generates $7.88 million in revenue each year. The company earns $-22,630,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis. Newron Pharmaceuticals employs 26 workers across the globe.

What is Newron Pharmaceuticals' official website?

The official website for Newron Pharmaceuticals is www.newron.com.

How can I contact Newron Pharmaceuticals?

Newron Pharmaceuticals' mailing address is via Antonio Meucci 3 Milan, Bresso L6, 20091. The company can be reached via phone at 39026103461 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.